Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy

Buchroithner J, Pichler J, Marosi C, Widhalm G, Seiz-Rosenhagen M, Novosielski M, Oberndorfer S, Ruckser R, Roessler K, Azizi A, Von Campe G, Bordihn K, Felzmann T (2014)

Publication Type: Journal article

Publication year: 2014

Journal

International Journal of Clinical Pharmacology and Therapeutics Dustri-Verlag

Publisher: Dustri-Verlag

Book Volume: 52

Pages Range: 76-7

Journal Issue: 1

DOI: 10.5414/CPXCES13EA02

Involved external institutions

Kepler Universitätsklinikum (KUK) AT Austria (AT) Medizinische Universität Wien AT Austria (AT) Medizinische Universität Innsbruck AT Austria (AT) Universitätsklinikum St. Pölten AT Austria (AT) Sozialmedizinisches Zentrum Ost – Donauspital (SMZ Ost) AT Austria (AT) Medizinische Universität Graz AT Austria (AT) Paracelsus Medizinische Privatuniversität AT Austria (AT) Activartis Biotech GmbH AT Austria (AT)

How to cite

APA:

Buchroithner, J., Pichler, J., Marosi, C., Widhalm, G., Seiz-Rosenhagen, M., Novosielski, M.,... Felzmann, T. (2014). Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy. International Journal of Clinical Pharmacology and Therapeutics, 52(1), 76-7. https://dx.doi.org/10.5414/CPXCES13EA02

MLA:

Buchroithner, Johanna, et al. "Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy." International Journal of Clinical Pharmacology and Therapeutics 52.1 (2014): 76-7.

BibTeX: Download